Sevre-Long 200 mg, Kapseln retard

7680539520540 CH-53952 Kapseln

Associated product:

SEVRE-LONG caps ret 200 mg 30 pce
Sevre-Long 200 mg, Kapseln retard
Sevre-Long 200 mg, Kapseln retard
Sevre-Long 200 mg, Kapseln retard
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/05/2025
Summary of Product Characteristics
Français
13/05/2025
Summary of Product Characteristics
Italien
13/05/2025
Patient information leaflet
Allemand
16/10/2024
Patient information leaflet
Français
16/10/2024
Patient information leaflet
Italien
16/10/2024

Detailed composition

Substance Quantity Type Category
morphini sulfas pentahydricus
200.0 MG Substance WIZUS
morphinum
150.42 MG Substance Wirkstoff (Principe actif)
oleum vegetabile hydrogenatum
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
talcum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 171
- Substance FNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrium
0.015 MG Substance HBESI
gelatina
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 82.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2002

Authorization holder

Mundipharma Medical Company,

4052 Basel

Authorization information

Swissmedic authorization number
53952
Drug name
Sevre-Long, Kapseln retard
Galenic form
RETH
ATC Code
N02AA01
Authorization status
Z
Dispensing category
A+
First authorization
30/01/1997
Authorization expiration date
31/12/9999
IT Number
01.01.3.
Domain
Human medicine
Field of application
Opioides Analgetikum, Substitutionsbehandlung bei Opioidabhängigkeit

Package details

Description (FR)
SEVRE-LONG caps ret 200 mg 30 pce
Description (DE)
SEVRE-LONG Ret Kaps 200 mg 30 Stk
Market launch
30/01/1997
Narcotic (BTM)
A

Other package sizes (5)

SEVRE-LONG caps ret 30 mg 30 pce
30 KAP
GTIN: 7680539520113
View
SEVRE-LONG caps ret 60 mg 30 pce
30 KAP
GTIN: 7680539520380
View
SEVRE-LONG caps ret 120 mg 100 pce
100 KAP
GTIN: 7680539520014
View
SEVRE-LONG caps ret 120 mg 30 pce
30 KAP
GTIN: 7680539520465
View
SEVRE-LONG caps ret 200 mg 100 pce
100 KAP
GTIN: 7680539520021
View
Buy us a coffee Explore the data